Future Indications
Harness the Power of RNA biomarkers
Caldera sees an opportunity to harness the great power of RNA biomarkers and our expertise in this area by developing specific devices/techniques that capture specific cell or vesicle types from non-invasive samples to which RNA signatures can be applied.
Our Patented Discovery Method
Our patented discovery method will be used to identify gene signatures in new indications such as:
- Companion diagnostics to aid therapy selection and to monitor drug efficacy and resistance (personalised therapy)
- Other cancers/conditions
